Resilience Secures $25M Funding for Healthtech Expansion
Healthtech Startup Resilience Secures $25M Funding for Remote Patient Monitoring Platform
Healthtech company Resilience has successfully secured $25 million in funding. The company has already deployed its remote patient monitoring platform in over 90 medical centers, benefiting more than 10,000 patients. Their mobile app for cancer patients has gained recognition in France as the first remote monitoring medical device in oncology to receive national social security reimbursement.
The funding round is led by Picus Capital and Red River West, with participation from Cathay Innovation, Singular, and Seaya Ventures. Resilience plans to expand its deployment in Belgium and strengthen its presence in Germany, where approximately 500,000 new cancer cases are reported each year. The co-founders' commitment to enhancing patient care through a holistic approach will be further supported by the new funds, accelerating their solution's deployment in France and globally.
Key Takeaways
- Healthtech company Resilience secures $25 million funding for its remote patient monitoring platform
- Already deployed in over 90 medical centers, serving 10,000 patients
- First remote monitoring medical device in oncology to be reimbursed by French national social security
- Plans to expand in Belgium and Germany, targeting 500,000 new cancer cases annually
- Funding to accelerate solution deployment in France and abroad
Analysis
The funding success will drive Resilience's expansion in Belgium and Germany, with a focus on half a million new cancer cases annually. As a pioneer in the reimbursed remote monitoring oncology device market in France, Resilience is set to strengthen its position, contributing to growth in the EU's healthcare sector. This development may encourage heightened investments in digital health solutions, ultimately enhancing patient care and outcomes. This shift will prompt traditional healthcare providers to adapt their service models to integrate tech-driven innovations and prepare insurers for potential increases in claims from remote monitoring adoption.
Did You Know?
- Remote Patient Monitoring (RPM) Platform: Advanced healthcare technology enabling healthcare professionals to monitor patients' health outside of traditional clinical settings, allowing for timely intervention and improved patient outcomes.
- Class IIa Medical Device: Category of medical devices defined by the European Union's Medical Device Regulation, posing minimal potential harm to patients, including monitoring devices like Resilience's platform.
- French National Social Security Reimbursement: Mechanism covering healthcare costs for specific medical devices, treatments, or services, indicating the significant value of Resilience's remote monitoring platform in improving patient care and reducing healthcare costs.